The P-O-ethyl ester of cAMP has been synthesized, its inhibition of solid and ascites tumors studied, and its pattern of urinary excretion followed. Et-cAMP is more effective than cAMP against solid sarcoma The recognition that altered cAMP levels may be an important biochemical lesion underlying diverse human diseases (1) has opened new avenues of rational drug design (2). Of the great variety of cAMP derivatives and analogs reported over the years (3), phosphotriesters of cAMP (4) offer the combined advantage of metabolic stability and cell penetration. This rationale led Nagyvary et al. (4) to the synthesis of several protected and unprotected (5) cAMP P-O-alkyl esters. The N6-diacetyl derivatives of Me-cAMP and Et-cAMP were found active on Ehrlich ascites carcinoma both in vivo and in vitro (4). It was proposed that the biological activity of these triesters could be linked to their functioning as storage forms of cAMP, which is known to inhibit tumors (6).
The recognition that altered cAMP levels may be an important biochemical lesion underlying diverse human diseases (1) has opened new avenues of rational drug design (2) . Of the great variety of cAMP derivatives and analogs reported over the years (3) , phosphotriesters of cAMP (4) offer the combined advantage of metabolic stability and cell penetration. This rationale led Nagyvary et al. (4) to the synthesis of several protected and unprotected (5) cAMP P-O-alkyl esters. The N6-diacetyl derivatives of Me-cAMP and Et-cAMP were found active on Ehrlich ascites carcinoma both in vivo and in vitro (4) . It was proposed that the biological activity of these triesters could be linked to their functioning as storage forms of cAMP, which is known to inhibit tumors (6) .
In the chemical synthesis (4) , cAMP was reacted with triisopropyl benzenesulfonyl chloride and the resulting mixed anhydride was subjected to alcoholysis. Although a transesterification leading to a neutral cAMP phosphoamidate was reported to be highly stereoselective for the exo form (7), two diastereomers are possible here. Thus, to establish the exact structure of the biologically active P-O-ethyl ester of cAMP studied in this work, its crystal structure was determined. This paper reports the results of this determination as well as some evidence of the superiority of this neutral ester to exogenous cAMP as a biologically active agent.
MATERIALS AND METHODS
Crystallography. Precession photographs of a needle-shaped crystal, 0.4 X 0.04 X 0.04 mm, established that the crystal belonged to the monoclinic space groups P21 (C22) or P21/ m(C2h2). The latter would be inconsistent with the chirality of the molecules and was also disfavored by the statistical distribution of the normalized structure factors. All further measurements were made on a Syntex P1 diffractometer utilizing incident beam monochromatized Mo Ka radiation.
Fifteen medium-angle reflections gave refined unit cell dimensions of a = 10.340 (7) (14) .
Glycogenolysis. Liver slices, 1.5-2.0 mm, were prepared from Swiss albino mice and incubated at 370 with cyclic nucleotides in Krebs-Henseleit buffer containing 40 mg/liter of neomycin. Glucose was measured according to Cawley et al. (10) .
Urinary Excretion of cAMP and Et-cAMP in laboratory white rats (300 g) after subcutaneous injection of Et-cAMP was measured for 10 hr/day.
RESULTS Biological
Stimulated by the putative relationship between cAMP and cancer (6), these preliminary experiments were designed to test the prediction, based solely on structure and chemistry, that Et-.cAMP would be superior to cAMP whenever sustained action is desired. Et-cAMP was found active on sarcoma 180 (Table 1) both subcutaneously and intraperitoneally, while cAMP had no effect. The relatively modest tumor inhibition could have almost certainly been improved, had our small supply of this drug not precluded daily injections from day one on. Finding the best dose regimen should yield further improvement, since significant iinhibition of lymphosarcoma (11) and Walker carcinosarcoma (12) has been reported to require daily single or multiple injections of cAMP. Fig. 1 shows the effect of Et-cAMP on Ehrlich ascites carcinoma cells grown in suspension culture. The amount of triester necessary to completely arrest cell division is about 100 times smaller than that of cAMP. At 10 jg/ml the triester is mildly, at 100 jAg/ml strongly, cytotoxic.
Urinary excretion of the triester and cAMP in rats was followed daily for 10 hr periods after a single subcutaneous injection on three successive days, of 13 /Amol of Et-cAMP per rat. Triester was detected in urine within 1 hr and declined sharply after 5 hr. From Table 2 one can deduce that approximately two-thirds of the injected Et-cAMP was retained in the rat, with the'same phenomenon being observed on the three consecutive days of injection. The amount of cAMP excreted on days 1-3 showed a steady increase and eventually became three titnes the amount found on 22 days after the treatment. The amount of cAMP excreted on day 22 was in the normal range found by others (15) .
To elaborate further on the assumption that biological effects of Et-cAMP' are due to cAMP production, we have studied glycogenolysis in liver slices from Swiss mice. This system was chosen because the Et-cAMP itself caused only insignifi- (Fig. 2) .
Description of the structure
The molecular structure with its atomic numbering scheme is shown in Fig. 3 . Positional and thermal parameters, bond distances, and bond angles are given in Tables 3-5 Sundaralingam (25) , the pseudorotational phase angle, P, and the maximum amplitude of puckering, rm, of 44°and 49°, respectively, are comparable to the values found in other cyclic nucleotides (22) .
As in the other cyclic nucleotide structures (18) (19) (20) (21) (22) (23) , the conformation about the C4'-C5' bond is fixed as trans-gauche. The six-membered phosphodiester ring is in a distorted chair conformation with the largest degree of pucker occurring at the C3'-C4' inter-ring junction. The P-O-ethyl group is axial, as is the comparable oxygen in the other cyclic nucleotide structures (18) (19) (20) (21) (22) (23) . In Et-cAMP this ring is somewhat more flattened than that seen in the other cyclic nucleotides. The ethyl group is in the endo configuration with respect to the base ring. The phosphate is essentially tetrahedral with an average O-P-O angle of 109°and reasonable P-O bond distances. The average P-O-C angle is 1180. All hydrogen bonding is intermolecular and shows no unusual features. There are no base ring-base ring stacking interactions.
DISCUSSION
Et-cAMP and other P-O-alkyl esters of cAMP are effective inhibitors of tumor growth. Our selected biological experiments can best be interpreted at this time in terms of facile cellular penetration and intracellular retention of the neutral triester followed by conversion to cAMP itself. The mecha- 
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